Skip to content
Screener

Baxter International BAX Medical Products & Therapies — Depreciation

Other segment segments

Healthcare Systems & Technologies
$24M-11.1%
Pharmaceuticals
$16M0.0%

Similar metrics at other companies

Methode Electronics logo
MEIMedical — Depreciation
$0—
MarineMax logo
HZOProduct Manufacturing — Depreciation
$1.81M+4.7%
Sunbelt Rentals Holdings logo
SUNBSpecialty — Depreciation
$141M+6.0%
Sunbelt Rentals Holdings logo
SUNBU.K. — Depreciation
$43M+2.4%
Cato Corporation logo
CATOCredit — Depreciation
$0—
Cato Corporation logo
CATORetail — Depreciation
$2.24M-12.8%

Other financials

Income statement

See full
Revenue$2.7B+2.9%
Gross profit$891.0M+3.5%
Operating income$66.0M+13.8%
Net income-$15.0M-112%
EPS (diluted)-$0.03-112%

Balance sheet

See full
Cash & equivalents$2.0B-12.1%
Total debt$224.0M-8.9%
Total equity$6.0B-14.7%
Total assets$19.8B-6.8%

Cash flow

See full
Operating cash flow$213.0M+210%
CapEx$128.3M+15.0%
Free cash flow$83.0M-42.1%

Valuation

See full
Market cap$14.13B+22.3%
Enterprise value$12.33B+22.1%
P/S1.3×+0.2×

Profitability

See full
Gross margin30.1%-5.9pp
Operating margin-2.7%—
Net margin-9.7%+62.5pp
FCF margin3%-2.4pp

Returns & leverage

See full
Return on equity-16.7%-76.7pp
Debt / equity0×0.0×
Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept us-gaap:Depreciation.

The source filing: Baxter International’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 4:50 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-028962
(in millions)Three Months Ended March 31, 2026Three Months Ended March 31, 2025
Depreciation Expense1
Medical Products & Therapies$51$49
Healthcare Systems & Technologies2427
Pharmaceuticals1616
Total depreciation expense$91$92

Item 1. Financial Statements (unaudited)

FAQ

What is Baxter International's medical products & therapies — depreciation?
Baxter International (BAX) reported medical products & therapies — depreciation of $51M in Q1 2026.
How has Baxter International's medical products & therapies — depreciation changed year-over-year?
Baxter International's medical products & therapies — depreciation increased by 4.1% year-over-year, from $49M to $51M.
What is the long-term trend for Baxter International's medical products & therapies — depreciation?
Over 4 years (2021 to 2025), Baxter International's medical products & therapies — depreciation has grown at a -0.8% compound annual growth rate (CAGR), from $213M to $206M.
What does medical products & therapies — depreciation mean?
The systematic allocation of the cost of tangible assets, such as manufacturing equipment and facilities, used by the Medical Products & Therapies segment over their useful lives. It reflects the wear and tear of the capital base required to support segment operations.

Ask your AI about Baxter International's medical products & therapies — depreciation.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude